Combined Apocynin and Novokinin Treatment Attenuates Renal Damage and Reduces KIM-1 Expression in a Model of Ischemic

Milan Ivanov1, Nevena Mihailović-Stanojević1, Una-Jovana Vujačić1

  • 1Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr Subotića 4, 11000 Belgrade, Serbia.

Insights

Targeting both NADPH oxidase and angiotensin II type 2 receptors may offer a promising therapeutic strategy for kidney ischemia-reperfusion injury (IRI). Combined treatment significantly reduced kidney injury and oxidative stress in a rat model.

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Oxidative Stress

Background:

  • Kidney ischemia-reperfusion injury (IRI) is a significant clinical challenge with incompletely understood mechanisms.
  • NADPH oxidase and angiotensin II type 2 receptors (AT2R) are implicated in the pathogenesis of ischemic acute kidney injury (AKI).

Purpose of the Study:

  • To investigate the therapeutic effects of apocynin (APO), an NADPH oxidase inhibitor, and novokinin (NOV), an AT2R agonist, on kidney IRI in spontaneously hypertensive rats (SHR).
  • To evaluate the combined efficacy of APO and NOV in mitigating kidney damage and oxidative stress.

Main Methods:

  • Spontaneously hypertensive rats (SHR) underwent induced kidney IRI and were divided into five groups: Sham-operated, AKI, and AKI treated with APO, NOV, or both.
  • Renal function, kidney injury molecule-1 (KIM-1) levels, and oxidative stress markers were assessed.

Main Results:

  • All treatments showed slight improvements in renal function.
  • The combination of APO and NOV significantly reduced KIM-1 levels and oxidative stress compared to the control AKI group.
  • Additive effects were observed when targeting both NADPH oxidase and AT2R.

Conclusions:

  • Combined inhibition of NADPH oxidase and AT2R activation offers superior therapeutic benefits for kidney IRI than individual treatments.
  • This dual-targeting strategy presents a potentially promising approach for managing AKI in critically ill patients.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...